ERBB2 and neoplasm: Interestingly, a pathologist-guided, region-specific analysis revealed that PD-L1 expression rarely overlaps with HER2-positive areas, suggesting that PD-L1 and HER2 biomarkers may bear mutually exclusive expression patterns in tumor specimens.